
Dixon Terry
Chief Compliance Officer
Dixon Terry joined BioLab Holdings in May 2025 as Chief Compliance Officer, bringing 30 years of leadership experience in the biopharmaceutical and medical device industry in both start-up and mid to large size companies. Prior to joining BioLab, Mr. Terry spent a majority of his career at Amgen, leading teams across multiple functions including clinical development, sales and compliance. In addition, Mr. Terry has led compliance functions at start-up biopharma companies and managed compliance programs both in the U.S. and global markets including management of Corporate Integrity Agreements.
Mr. Terry holds a Bachelor’s Degree in Psychology and a Master’s in Public Health
Contact us:
We welcome your thoughts, questions, and insights. Whether you're a partner, provider, patient, or simply curious about our mission, your message matters to us — and to me personally. Please use the form below to get in touch. Our team will ensure your message is directed appropriately, and when needed, I’ll be sure to see it myself.